Patents by Inventor Douglas D. Burkett

Douglas D. Burkett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7736625
    Abstract: Photochemical demethylation reactions in solutions of thiazine dyes, in which the dye molecules act as both sensitizer and substrate, are reduced by quenching triple-state dye molecules, returning them to the unreactive ground state.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: June 15, 2010
    Assignee: Zila, Inc.
    Inventor: Douglas D. Burkett
  • Patent number: 7659057
    Abstract: The location at which tissue samples are obtained to determine whether cells exhibit characeristics associated with cell differentiation or cancer by molecular analysis is determined by topically applying to epithelial tissue a dye that selectively stains cancer and precancerous tissue.
    Type: Grant
    Filed: October 5, 2002
    Date of Patent: February 9, 2010
    Assignee: Zila Biotechnology, Inc.
    Inventor: Douglas D. Burkett
  • Publication number: 20090124897
    Abstract: In a light-directed method of identifying abnormal mucosal tissue, any suspect sites revealed by a light that selectively aids in visualizing abnormal tissue are marked with a dye facilitate further evaluation of the suspect tissue.
    Type: Application
    Filed: September 30, 2004
    Publication date: May 14, 2009
    Applicant: ZILA BIOTECHNOLOGY, INC.
    Inventor: Douglas D. Burkett
  • Publication number: 20090092552
    Abstract: Photochemical demethylation reactions in solutions of thiazine dyes, in which the dye molecules act as both sensitizer and substrate, are reduced by quenching triple-state dye molecules, returning them to the unreactive ground state.
    Type: Application
    Filed: December 8, 2008
    Publication date: April 9, 2009
    Applicant: ZILA BIOTECHNOLOGY, INC.
    Inventor: Douglas D. BURKETT
  • Publication number: 20090023138
    Abstract: Methods of detecting progression from precancer to cancer are provided utilizing toluidine blue staining as well as detecting allelic variation at microsatellite loci. An allelic variation in one or more locus is indicative of a progression from precancer to cancer.
    Type: Application
    Filed: July 17, 2007
    Publication date: January 22, 2009
    Applicant: ZILA BIOTECHNOLOGY, INC.
    Inventors: Douglas D. Burkett, David Sidransky, Antonette C.P. Allen, Francis A. Chiafari, Mark Bride, Yu Ping Maguire
  • Patent number: 7462346
    Abstract: Photochemical demethylation reactions in solutions of thiazine dyes, in which the dye molecules act as both sensitizer and substrate, are reduced by quenching triple-state dye molecules, returning them to the unreactive ground state.
    Type: Grant
    Filed: August 28, 2001
    Date of Patent: December 9, 2008
    Assignee: Zila Biotechnology, Inc.
    Inventor: Douglas D. Burkett
  • Patent number: 6967015
    Abstract: In diagnostic testing for cancer and precancer of the epithelium, the undesired binding of cancer-selective dyes to proteins in the extracellular matrix, which may lead to false positives, is reduced by applying to the epithelium being tested, before application of the dye, a solution of a non-toxic amphiphilic protein in a pharmacolgically acceptable solvent.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: November 22, 2005
    Assignee: Zila, Inc.
    Inventor: Douglas D. Burkett
  • Patent number: 6830743
    Abstract: Compounds having the structural formula (A) wherein X is hydrogen, methyl, or Y; Y is —NH—R or hydrogen; and R is methyl or formula (B) are useful as in vivo stains for the detection of dysplastic tissue.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: December 14, 2004
    Assignee: Zila Biotechnology, Inc.
    Inventor: Douglas D. Burkett
  • Publication number: 20040247695
    Abstract: Photochemical demethylation reactions in solutions of thiazine dyes, in which the dye molecules act as both sensitizer and substrate, are reduced by quenching triple-state dye molecules, returning them to the unreactive around state.
    Type: Application
    Filed: February 17, 2004
    Publication date: December 9, 2004
    Inventor: Douglas D Burkett
  • Publication number: 20040235067
    Abstract: The location at which tissue samples are obtained to determine whether cells exhibit characeristics associated with cell differentiation or cancer by molecular analysis is determined by topically applying to epithelial tissue a dye that selectively stains cancer and precancerous tissue.
    Type: Application
    Filed: June 16, 2004
    Publication date: November 25, 2004
    Inventor: Douglas D Burkett
  • Publication number: 20040146919
    Abstract: A prognostic method for early prediction of eventual development of invasive cancer comprises identifying suspect cancerous and precancerous tissue sites by applying a dye which selectively stains such sites, followed by molecular genetic analysis to determine whether the DNA of such sites exhibits allelic losses for mutation of tumor suppressor genes.
    Type: Application
    Filed: January 14, 2004
    Publication date: July 29, 2004
    Inventor: Douglas D. Burkett
  • Patent number: 6649144
    Abstract: A diagnostic method for detecting cancerous epithelial cells by selectively marking the mitochondria of the cancer cells, by delivering to the epithelium a cationic supravital mitochondrial marking agent. Selective killing of cancerous epithelial cells in the presence of normal cells is effected by delivering a cationic supravital mitochondrial marking agent to epithelial cancer cells. The killing agent can also comprise the reaction product of the marking agent and a cancer chemotherapeutic drug.
    Type: Grant
    Filed: February 16, 2001
    Date of Patent: November 18, 2003
    Assignee: Zila, Inc.
    Inventors: Douglas D. Burkett, Ralph E. Green, Samuel D. Bernal
  • Publication number: 20030017158
    Abstract: A diagnostic method for detecting cancerous epithelial cells by selectively marking the mitochondria of the cancer cells, by delivering to the epithelium a cationic supravital mitochondrial marking agent. Selective killing of cancerous epithelial cells in the presence of normal cells is effected by delivering a cationic supravital mitochondrial marking agent to epithelial cancer cells.
    Type: Application
    Filed: March 8, 2002
    Publication date: January 23, 2003
    Inventors: Samuel D. Bernal, Douglas D. Burkett, Ralph E. Green, Seth D. Rose
  • Publication number: 20020111501
    Abstract: A process for synthesizing 2-amino-5-dimethlyaminophenyl thiosulfonic acid comprises the step of oxidizing N,N′-dimethyl-&rgr;-phenylene-diamine in the presence of a source of thiosulfate ions, while maintaining the temperature of the reaction mixture not higher than about 10° C. This compound is useful as an intermediate in the synthesis of toluidine blue ∘.
    Type: Application
    Filed: March 11, 2002
    Publication date: August 15, 2002
    Inventor: Douglas D. Burkett
  • Patent number: 6372904
    Abstract: A process for synthesizing 2-amino-5-dimethlyaminophenyl thiosulfonic acid comprises the step of oxidizing N,N′-dimethyl-&rgr;-phenylene-diamine in the presence of a source of thiosulfate ions, while maintaining the temperature of the reaction mixture not higher than about 10° C. This compound is useful as an intermediate in the synthesis of toluidine blue O. A process for manufacturing toluidine blue O with improved yield, includes the step of preparing the intermediate 2-amino-5-diethylaminopropyl thiosulfonic acid according to the above described procedure.
    Type: Grant
    Filed: January 11, 2001
    Date of Patent: April 16, 2002
    Assignee: Zila, Inc.
    Inventor: Douglas D. Burkett
  • Publication number: 20010007904
    Abstract: A process for synthesizing 2-amino-5-dimethlyaminophenyl thiosulfonic acid comprises the step of oxidizing N,N′-dimethyl-&rgr;-phenylene-diamine in the presence of a source of thiosulfate ions, while maintaining the temperature of the reaction mixture not higher than about 10° C. This compound is useful as an intermediate in the synthesis of toluidine blue O.
    Type: Application
    Filed: January 11, 2001
    Publication date: July 12, 2001
    Inventor: Douglas D. Burkett
  • Patent number: 6194573
    Abstract: A process for synthesizing 2-amino-5-dimethlyaminophenyl thiosulfonic acid comprises the step of oxidizing N,N′-dimethyl-&rgr;-phenylene-diamine in the presence of a source of thiosulfate ions, while maintaining the temperature of the reaction mixture not higher than about 10° C. This compound is useful as an intermediate in the synthesis of toluidine blue O. A process for manufacturing toluidine blue O with improved yield, includes the step of preparing the intermediate 2-amino-5-diethylaminopropyl thiosulfonic acid according to the above described procedure.
    Type: Grant
    Filed: July 6, 1998
    Date of Patent: February 27, 2001
    Assignee: Zila, Inc.
    Inventor: Douglas D. Burkett
  • Patent number: 6086852
    Abstract: N-demethylated and N,N-demethylated derivatives of toluidine blue O and compositions which include these derivatives and the conformational isomers of toluidine blue O. Improved methods for the detection of dysplastic oral tissue using such compositions.Processes for synthesis of toluidine blue O products, in which a complexing agent is introduced prior to the last stage of oxidation of a three-step synthesis from N,N-dimethyl-.rho.-phenylenediamine.An HPLC method for characterizing toluidine blue O products in which the mobile phase is an aqueous solution of an organic acid.
    Type: Grant
    Filed: May 20, 1999
    Date of Patent: July 11, 2000
    Assignee: Zila, Inc.
    Inventor: Douglas D. Burkett